Acute respiratory distress syndrome: Physiology and new management strategies

Annual Review of Medicine

Volumn 52, Issue , 2001, Pages 221-237

  Weinacker, A B ^a   Vaszar, L T ^a  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Acute respiratory failure; Corticosteroids; Inverse ratio ventilation; Lung protective ventilation; Nitric oxide

Indexed keywords

CORTICOSTEROID; NITRIC OXIDE;

ACUTE DISEASE; ADULT RESPIRATORY DISTRESS SYNDROME; ARTIFICIAL VENTILATION; CLINICAL FEATURE; HUMAN; HYALINE MEMBRANE DISEASE; HYPOXEMIA; INFLAMMATORY CELL; LUNG COMPLIANCE; LUNG EDEMA; LUNG FIBROSIS; LUNG INFILTRATE; LUNG INJURY; PATHOPHYSIOLOGY; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; RESPIRATORY FAILURE; REVIEW; SURVIVAL RATE; THORAX RADIOGRAPHY; TIDAL VOLUME; VASODILATATION;

AIRWAY RESISTANCE; ANTI-INFLAMMATORY AGENTS; FORECASTING; HUMANS; INFLAMMATION; INTENSIVE CARE; LUNG COMPLIANCE; NITRIC OXIDE; POSITIVE-PRESSURE RESPIRATION; RESPIRATORY DISTRESS SYNDROME, ADULT; STEROIDS; SURVIVAL ANALYSIS; TIDAL VOLUME; TREATMENT OUTCOME; VASODILATOR AGENTS;

EID: 0035123542     PISSN: 00664219     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.med.52.1.221     Document Type: Review

References (60)

1. Acute respiratory distress in adults
2. An expanded definition of the adult respiratory distress syndrome
3. Definitions, mechanisms, relevant outcomes, and clinical trial coordination
4. Epidemiology of acute lung injury and ARDS
5. Adult respiratory distress syndrome - How many cases in the UK?
6. The incidence of the adult respiratory distress syndrome
7. Incidence, severity, and mortality of acute respiratory failure in Berlin, Germany
8. Incidence of the adult respiratory distress syndrome in the state of Utah
9. Incidence and mortality after acute respiratory failure and acute respiratory distress syndrome in Sweden, Denmark, and Iceland
10. Clinical risks for development of the acute-respiratory distress syndrome
11. The acute respiratory distress syndrome
12. Pulmonary edema
13. Biological markers of acute lung injury: Prognostic and pathogenetic significance
14. Acute respiratory distress syndrome. Cellular biology and pathology
15. A lung-protective approach to ventilating ARDS
16. Intermittent positive-pressure hyperventilation with high inflation pressures produces pulmonary microvascular injury in rats
17. Adverse effects of large tidal volume and low PEEP in canine acid aspiration
18. Ventilator-induced lung injury: Lessons from experimental studies
19. Effect of mechanical ventilation on inflammatory mediators in patients with acute respiratory distress syndrome: A randomized controlled trial
20. Histologic aspects of pulmonary barotrauma in critically ill patients with acute respiratory failure
21. Mechanisms of ventilator-induced lung injury
22. Barotrauma is volutrauma, but which volume is the one responsible?
23. Low mortality associated with low volume pressure limited ventilation with permissive hypercapnia in severe adult respiratory distress syndrome
24. Effect of a protective-ventilation strategy on mortality in the acute respiratory distress syndrome
25. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome
26. Temporal hemodynamic effects of permissive hypercapnia associated with ideal PEEP in ARDS
27. Safety and efficacy of a sustained inflation for alveolar recruitment in adults with respiratory failure
28. The prone position in ARDS patients. A clinical study
29. Effects of the prone position on gas exchange and hemodynamics in severe acute respiratory distress syndrome
30. Prone positioning of patients with acute respiratory distress syndrome: A systematic review
31. Acute respiratory distress syndrome. Patient position and motion strategies
32. Influence of positioning on ventilation-perfusion relationships in severe adult respiratory distress syndrome
33. Pressure controlled inverse ratio ventilation in severe adult respiratory failure
34. Improved oxygenation and lower peak airway pressure in severe adult respiratory distress syndrome. Treatment with inverse ratio ventilation
35. Hemodynamic and ventilatory effects associated with increasing inverse inspiratory-expiratory ventilation
36. Volume-controlled ventilation and pressure-controlled inverse ratio ventilation: A comparison of their effects in ARDS patients
37. Effects of pressure-controlled with different I:E ratios versus volumecontrolled ventilation on respiratory mechanics, gas exchange, and hemodynamics in patients with adult respiratory distress syndrome
38. Inverse ratio ventilation (I/E = 2/1) in acute respiratory distress syndrome: A six-hour controlled study
39. Inhaled nitric oxide for the adult respiratory distress syndrome
40. Inhaled nitric oxide selectively reverses human hypoxic pulmonary vasoconstriction without causing systemic vasodilation
41. Inhaled nitric oxide
42. Effects of inhaled nitric oxide in patients with acute respiratory distress syndrome: Results of a randomized phase II trial
43. Efficiency of inhaled nitric oxide as rescue therapy during severe ARDS: Survival and factors associated with the first response
44. Inhalation of nitric oxide in acute lung injury: Results of a European multicentre study
45. The adult respiratory distress syndrome: Clinical features, factors influencing prognosis and principles of management
46. Early steroid therapy for respiratory failure
47. The effects of high-dose corticosteroids in patients with septic shock. A prospective, controlled study
48. High-dose corticosteroids in patients with the adult respiratory distress syndrome
49. Ineffectiveness of highdose methylprednisolone in preventing parenchymal lung injury and improving mortality in patients with septic shock
50. Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome: A randomized controlled trial
51. Methylprednisolone for unresolving ARDS
52. Corticosteroid therapy in acute respiratory distress syndrome: Better late than never?
53. Liquid ventilation
54. Aerosolized surfactant in adults with sepsis-induced acute respiratory distress syndrome
55. Improved prognosis of acute respiratory distress syndrome 15 years on
56. Causes of mortality in patients with the adult respiratory distress syndrome
57. Identification of patients with acute lung injury. Predictors of mortality
58. Reduced quality of life in survivors of acute respiratory distress syndrome compared with critically ill control patients
59. Long-term follow-up of survivors of acute lung injury: Lack of effect of a ventilation strategy to prevent barotrauma
60. Neuropsychological sequelae and impaired health status in survivors of severe acute respiratory distress syndrome